Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY24.26 CNY
Change Today -0.53 / -2.14%
Volume 24.8M
600572 On Other Exchanges
As of 3:05 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang conba pharmaceuti-a (600572) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/14/15 - CNY25.92
52 Week Low
05/19/14 - CNY12.72
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ZHEJIANG CONBA PHARMACEUTI-A (600572)

Related News

No related news articles were found.

zhejiang conba pharmaceuti-a (600572) Related Businessweek News

No Related Businessweek News Found

zhejiang conba pharmaceuti-a (600572) Details

Zhejiang Conba Pharmaceutical Co., Ltd. manufactures and sells medicines and chemical products in the People’s Republic of China. The company was founded in 1969 and is based in Hangzhou, the People’s Republic of China.

Founded in 1969

zhejiang conba pharmaceuti-a (600572) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang conba pharmaceuti-a (600572) Key Developments

Zhejiang Conba Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Three Quarters of 2014

Zhejiang Conba Pharmaceutical Co.,Ltd. reported earnings results for the first three quarters of 2014. For the period, the company reported basic earnings per share of CNY 0.49. Weighted average return on net assets was 15.74%.

Zhejiang Conba Pharmaceutical Co.,Ltd., Board Meeting, Oct 29, 2014

Zhejiang Conba Pharmaceutical Co.,Ltd., Board Meeting, Oct 29, 2014. Agenda: To discuss and approve issues including the third quarter report of 2014; to approve proposal of change of accounting policy and adjusting relevant financial information; and to approve the proposal of establishing Conba Company Central Research Institute.

Zhejiang Conba Pharmaceutical Co.,Ltd. to Report Q3, 2014 Results on Oct 30, 2014

Zhejiang Conba Pharmaceutical Co.,Ltd. announced that they will report Q3, 2014 results on Oct 30, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600572:CH CNY24.26 CNY -0.53

600572 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600572.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600572 Industry Range
Price/Earnings 38.5x
Price/Sales 5.9x
Price/Book 7.6x
Price/Cash Flow 46.4x
TEV/Sales 6.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG CONBA PHARMACEUTI-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at